FDA panel rejects Philip Morris’s claims that new smokeless cigarette reduces harm

An U.S. advisory panel on Thursday rejected claims by Philip Morris International that a new smokeless cigarette it hopes to sell in the United States reduces the risk and harm of smoking. The panel, convened by the Food and Drug Administration, agreed with the company's claim that its smokeless cigarette reduces smokers’ exposure to harmful […]

Related:
Here’s what you should know about the flu season this year
Marijuana-based anti-seizure drug could hit U.S. market in 2018 after strong study results
Paramedics said her 6-year-old had common flu symptoms and left, she claims. Now her daughter is dead.

Share Share Tweet Share Share Share

Home

Thanks For You Reading The Post We are very happy for you to come to our site. Our Website Domain name https://leomedtrends.blogspot.com/.